SNA vs STRO · P/E 17, rev $5.11B vs rev $62.0M
Snap-On Inc (SNA) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported SNA revenue for 2024-12-28 was $5.11B. Net income was $1.07B. Revenue was up 0.0% from 2023-12-30 to 2024-12-28. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
SNA currently screens at market cap $16.82B and trailing P/E 16.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the SNA and STRO stock pages for the full models.
Not investment advice.